Detalles de la búsqueda
1.
Favipiravir and/or nitazoxanide: a randomized, double-blind, 2×2 design, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE).
Trials
; 23(1): 583, 2022 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35869526
2.
Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE).
Trials
; 24(1): 347, 2023 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37218017
Resultados
1 -
2
de 2
1
Próxima >
>>